semaglutide from india The upcoming expiry of the patent in in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open India pharma companies develop versions

Trial REDEFINE 2 Phase 3 Duration 68 weeks Population (N) 1,206 adults with T2D + obesity/overweight Key Result 13.7% mean weight change vs 3.4% placebo (treatment-policy)

GLP1 weight loss shots like Wegovy, Ozempic, and Mounjaro have demonstrated remarkable effectiveness for menopause weight loss, with clinical studies showing they work equally well in postmenopausal women as in younger adults

Expected launch window: May 2026

Vitamin B12 deficiency has occurred in breast-fed infants of vegetarian mothers whose diets contain no animal products (e.g., eggs, dairy), even though the mothers had no symptoms of deficiency at the time